• Recent work has detailed the impact of genetic deletion

  2023-02-20

  

  Recent work has detailed the impact of genetic Alsterpaullone mg of AMPK in the liver, revealing only minor phenotypes upon removal in mice (Boudaba et al., 2018). However, these studies very elegantly showed the potential for small molecule-mediated activation of AMPK to elicit large changes in li

• Perhaps the first evidence of

  2023-02-20

  

  Perhaps the first evidence of AMPKs therapeutic ability in DM1 came from Thomas Cooper’s laboratory where they demonstrated that insulin-independent glucose uptake was unaffected in human DM1 muscle Pam3CSK4 Biotin treated with MET, an AMPK activator and first-line therapy for type 2 diabetes mellit

• Fmoc-Glu(OtBu)-OPfp br Regulation of BCAA catabolism The BCA

  2023-02-20

  

  Regulation of BCAA catabolism The BCAA catabolic system is equipped in mammalian cells to dispose of excess BCAAs, presumably resulting in relatively stable concentrations of BCAAs in blood and tissues in humans. The main BCAA catabolic pathway is localized in the mitochondria of all tissues. The

• br Introduction Myasthenia gravis MG is

  2023-02-16

  

  Introduction Myasthenia gravis (MG) is an autoimmune disease characterised by failure of transmission at the neuromuscular junction (NMJ). In 80–85% of myasthenia gravis patients, the disease is mediated by antibodies to the nicotinic Dihydroartemisinin synthesis receptor (AChR; (Lindstrom et al

• A high throughput screening campaign led to the discovery of

  2023-02-13

  

  A high-throughput screening campaign led to the discovery of the first series of both potent and selective ATR kinase inhibitors by Vertex Pharmaceuticals (Charrier et al., 2011). One of these compounds, VE-821, was shown to be a potent ATP-competitive inhibitor of ATR with minimal cross-reactivity

• br Conclusions A large body of evidence indicates

  2023-02-13

  

  Conclusions A large body of evidence indicates that oxidative stress is involved in the pathogenesis of NDDs. Hence, reducing oxidative stress or suppressing its downstream pathways may be beneficial for the treatment of these diseases, especially such chronic diseases as AD or glaucoma. Here we

• In conclusion our data highlight that variable anti oxidativ

  2023-02-13

  

  In conclusion, our data highlight that variable anti-oxidative CJ-42794 could be released through peptic hydrolysis of CMP fractions. Although casein hydrolysates produced a larger number of peptides (Table 1) with variable antioxidant capacities, all the peptides from whey hydrolysate exhibited hi

• Introduction Epinephrine is an endocrine hormone mainly prod

  2023-02-13

  

  Introduction Epinephrine is an endocrine hormone mainly produced by adrenal medulla in response to stress (Tank and Lee Wong, 2015). This catecholamine exerts various major physiological effects, concerning notably the cardiovascular system, the respiratory system and the endocrine system, through

• CH5138303 AdipoRon acts on the anti diabetic effects of adip

  2023-02-13

  

  AdipoRon acts on the anti-diabetic effects of adiponectin, exhibiting its effect through the activation of AMPK and PPARα pathways via AdipoR1 and AdipoR2, respectively [23]. AdipoR activation is a promising treatment for diabetes, nonalcoholic fatty liver disease, and cardiovascular disease, demons

• 6206 synthesis In this study we make the first simultaneous

  2023-02-13

  

  In this study, we make the first simultaneous recordings of 6206 synthesis release in multiple brain regions at a temporal resolution less than 1 s. One of the most striking findings is that acetylcholine release has a remarkably similar temporal profile in the mPFC and dHPC, suggesting a coordinate

• An AXL decoy receptor with enhanced

  2023-02-10

  

  An AXL decoy receptor with enhanced GAS6-binding properties, MYD1, was engineered as a therapeutic tool to disrupt GAS6/AXL signaling in vivo (Kariolis et al., 2014). MYD1 was shown to block metastasis of human ovarian cancer jc1 and a murine breast cancer cell line in grafting assays in mice. These

• br Perspective AA LA and other

  2023-02-10

  

  Perspective AA, LA and other PUFAs and their lipid metabolites play an important role in human diseases. 12/15-LOX which is the metabolic enzyme of them plays an important role in the pathogenesis-related diseases such as atherosclerosis, diabetic nephropathy, neurological diseases and other path

• Introduction The corpus luteum CL is a transient endocrine g

  2023-02-10

  

  Introduction The corpus luteum (CL) is a transient endocrine gland that differentiates from the thecal and granulosal cells of the ovarian follicle after ovulation. Its formation and limited lifespan in the mammalian ovary is important for fertility, as the CL produces progesterone (P4), the essent

• Serum concentrations of APP and antioxidants of the queens

  2023-02-10

  

  Serum concentrations of APP and antioxidants of the 10 queens with pyometra before surgery (T0), at day two (T1) and at day 10 (T2) after ovariohysterectomy are presented in Fig. 1. Concentrations of SAA and Hp were significantly lower (P  Discussion Acute phase protein responses were already desc

• This progressive behaviour is summarized in Fig which depict

  2023-02-10

  

  This progressive behaviour is summarized in Fig. 4, which depicts the variation in convexity of the obtained cut-off patterns for the series of six antioxidants. The form and degree of convexity of the obtained cut-off curves should in principle correlate with the AOs hydrophobicities, and therefor

15778 records 311/1052 page Previous Next First page 上5页 311312313314315 下5页 Last page